Sorry, We Can’t Find That PageThe link you clicked may be broken or this page has been removed (Error Code: 404).SuggestionsMultiple MyelomaODAC Votes on Two CAR-T Therapies in MyelomaYoussef RddadNews4 Min ReadMost ODAC members affirmed that the benefits of two CAR T-cell therapies outweigh potential early death risks in relapsed or refractory multiple myeloma. Multiple MyelomaODAC Votes on Two CAR-T Therapies in MyelomaYoussef RddadNews4 Min ReadMost ODAC members affirmed that the benefits of two CAR T-cell therapies outweigh potential early death risks in relapsed or refractory multiple myeloma. Business & PolicyFDA Cancer Drug Withdrawal Illustrates ConcernsNeil OsterweilNews5 Min ReadThe recent withdrawal a cancer drug that had been granted accelerated approval by the FDA may be illustrative of concerns raised by some critics. Business & PolicyFDA Cancer Drug Withdrawal Illustrates ConcernsNeil OsterweilNews5 Min ReadThe recent withdrawal a cancer drug that had been granted accelerated approval by the FDA may be illustrative of concerns raised by some critics. Endometrial and Uterine Cancers“Unprecedented” OS Gain Seen in Endometrial CancerLeah LawrenceNews3 Min Read“This is something that…should be incorporated into everyone’s practice yesterday,” one expert said. Endometrial and Uterine Cancers“Unprecedented” OS Gain Seen in Endometrial CancerLeah LawrenceNews3 Min Read“This is something that…should be incorporated into everyone’s practice yesterday,” one expert said. Chronic Lymphocytic Leukemia (CLL)FDA Approves First-Ever CAR-T Therapy in CLL, SLLMarcia FrellickNews3 Min ReadThe FDA approved lisocabtagene maraleucel for use in adult patients with relapsed or refractory CLL or SLL, the first CAR-T therapy to receive such approval. Chronic Lymphocytic Leukemia (CLL)FDA Approves First-Ever CAR-T Therapy in CLL, SLLMarcia FrellickNews3 Min ReadThe FDA approved lisocabtagene maraleucel for use in adult patients with relapsed or refractory CLL or SLL, the first CAR-T therapy to receive such approval. Business & PolicyPBM Reform Update: Major Changes Coming Soon?Aaron TallentNews3 Min ReadThe window for PBM reform this year is small; however, lawmakers are increasingly engaged on the issue, and major changes may arrive soon, experts say. Business & PolicyPBM Reform Update: Major Changes Coming Soon?Aaron TallentNews3 Min ReadThe window for PBM reform this year is small; however, lawmakers are increasingly engaged on the issue, and major changes may arrive soon, experts say. Business & PolicyPBM Reform Update: Major Changes Coming Soon?Aaron TallentNews3 Min ReadThe window for PBM reform this year is small; however, lawmakers are increasingly engaged on the issue, and major changes may arrive soon, experts say. Business & PolicyPBM Reform Update: Major Changes Coming Soon?Aaron TallentNews3 Min ReadThe window for PBM reform this year is small; however, lawmakers are increasingly engaged on the issue, and major changes may arrive soon, experts say. Lung CancerMore Immunotherapy AEs, Better Survival in NSCLC?Youssef RddadNews4 Min ReadImmune-related adverse events from immunotherapy for advanced NSCLC was tied to better survival, regardless of severity, although the link remains “contentious.” Lung CancerMore Immunotherapy AEs, Better Survival in NSCLC?Youssef RddadNews4 Min ReadImmune-related adverse events from immunotherapy for advanced NSCLC was tied to better survival, regardless of severity, although the link remains “contentious.” Urothelial CarcinomaFrom “Fairytale” to Reality in Bladder Cancer?Robert Dreicer, MD, Robert A. Figlin, MD, FACPPodcastRobert Dreicer, MD, and Robert A. Figlin, MD, discuss “paradigm-shifting” data in bladder cancer that mean optimistic outcomes are “not as much of a fairytale.” Urothelial CarcinomaFrom “Fairytale” to Reality in Bladder Cancer?Robert Dreicer, MD, Robert A. Figlin, MD, FACPPodcastRobert Dreicer, MD, and Robert A. Figlin, MD, discuss “paradigm-shifting” data in bladder cancer that mean optimistic outcomes are “not as much of a fairytale.” Business & PolicyOncology Clinics Sold Amid Major BankruptcyAaron TallentNews3 Min ReadOneOncology and Coastal Cancer Center have purchased two radiation oncology centers from GenesisCare as part of that company’s effort to emerge from bankruptcy. Business & PolicyOncology Clinics Sold Amid Major BankruptcyAaron TallentNews3 Min ReadOneOncology and Coastal Cancer Center have purchased two radiation oncology centers from GenesisCare as part of that company’s effort to emerge from bankruptcy. Practice ManagementIs Community-Based Oncology Training Deficient?Aaron TallentNews3 Min ReadRecent survey results point to what the authors call “substantial unmet needs” in terms of training hematology/oncology fellows for community-based careers. Practice ManagementIs Community-Based Oncology Training Deficient?Aaron TallentNews3 Min ReadRecent survey results point to what the authors call “substantial unmet needs” in terms of training hematology/oncology fellows for community-based careers. Breast CancerOvercoming ADC Resistance in Breast CancerNeil OsterweilNews5 Min ReadADCs are revolutionizing breast cancer care, but some patients quickly stop responding to them. Where do things stand in the fight to overcome ADC resistance? Breast CancerOvercoming ADC Resistance in Breast CancerNeil OsterweilNews5 Min ReadADCs are revolutionizing breast cancer care, but some patients quickly stop responding to them. Where do things stand in the fight to overcome ADC resistance? Patient CareSexual Health Oversight in Oncology Training?Alicia AultNews5 Min ReadHematology and oncology fellowship programs devote little time to learning how to address sexual and reproductive health concerns, according to a new survey. Patient CareSexual Health Oversight in Oncology Training?Alicia AultNews5 Min ReadHematology and oncology fellowship programs devote little time to learning how to address sexual and reproductive health concerns, according to a new survey. Load More